Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Aug 29:9:718.
doi: 10.3389/fneur.2018.00718. eCollection 2018.

MRI Markers and Functional Performance in Patients With CIS and MS: A Cross-Sectional Study

Affiliations

MRI Markers and Functional Performance in Patients With CIS and MS: A Cross-Sectional Study

Ludwig Rasche et al. Front Neurol. .

Abstract

Introduction: Brain atrophy is a widely accepted marker of disease severity with association to clinical disability in multiple sclerosis (MS). It is unclear to which extent this association reflects common age effects on both atrophy and function. Objective: To explore how functional performance in gait, upper extremities and cognition is associated with brain atrophy in patients with Clinically Isolated Syndrome (CIS) and relapsing-remitting MS (RRMS), controlling for effects of age and sex. Methods: In 27 patients with CIS, 59 with RRMS (EDSS ≤3) and 63 healthy controls (HC), 3T MRI were analyzed for T2 lesion count (T2C), volume (T2V) and brain volumes [normalized brain volume (NBV), gray matter volume (NGMV), white matter volume (NWMV), thalamic volume (NThalV)]. Functional performance was measured with short maximum walking speed (SMSW speed), 9-hole peg test (9HPT) and symbol digit modalities test (SDMT). Linear regression models were created for functional variables with stepwise inclusion of age, sex and MR imaging markers. Results: CIS differed from HC only in T2C and T2V. RRMS differed from HC in NBV, NGMV and NThalV, T2C and T2V, but not in NWMV. A strong association with age was seen in HC, CIS and RRMS groups for NBV (r = -0.5 to -0.6) and NGMV (r = -0.6 to -0.8). Associations with age were seen in HC and RRMS but not CIS for NThalV (r = -0.3; r = -0.5), T2C (rs = 0.3; rs = 0.2) and T2V (rs = 0.3; rs = 0.3). No effect of age was seen on NWMV. Correlations of functional performance with age in RRMS were seen for SMSW speed, 9HPTand SDMT (r = -0.27 to -0.46). Regression analyses yielded significant models only in the RRMS group for 9HPT, SMSW speed and EDSS. These included NBV, NGMV, NThalV, NWMV, logT2V, age and sex as predictors. NThalV was the only MRI variable predicting a functional measure (9HPTr) with a higher standardized beta than age and sex (R2 = 0.36, p < 1e-04). Conclusion: Thalamic atrophy was a stronger predictor of hand function (9HPT) in RRMS, than age and sex. This underlines the clinical relevance of thalamic atrophy and the relevance of hand function as a clinical marker even in mildly disabled patients.

Keywords: MSFC; atrophy; clinical outcomes; clinically isolated syndrome; functional performance; multiple sclerosis; thalamus.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Group comparisons of MRI parameters. Displayed are the respective MRI Parameters in healthy controls (HC), patients with clinically isolated syndrome (CIS) and relapsing-remitting multiple sclerosis (RRMS). The horizontal line represents the median, the box represents the upper and lower quartiles, whiskers represent the 1.5-fold IQR, outliers are encircled.
Figure 2
Figure 2
(A) Age dependency of MRI parameters in healthy controls (HC), patients with clinically isolated syndrome (CIS) and relapsing-remitting multiple sclerosis (RRMS). Displayed are the Pearson's r and p, except for T2C and T2V, where Spearmans rho and p are displayed. (B) Age dependency of functional performance in patients with clinically isolated syndrome (CIS) and relapsing-remitting multiple sclerosis (RRMS). Displayed are the Pearsons r and p.

Similar articles

Cited by

References

    1. Reich DS, Lucchinetti CF, Calabresi PA. Multiple Sclerosis. N Engl J Med. (2018) 378:169–80. 10.1056/NEJMra1401483 - DOI - PMC - PubMed
    1. Alcaide-Leon P, Cybulsky K, Sankar S, Casserly C, Leung G, Hohol M, et al. . Quantitative spinal cord MRI in radiologically isolated syndrome. Neurol Neuroimmunol Neuroinflamm. (2018) 5:e436. 10.1212/NXI.0000000000000436 - DOI - PMC - PubMed
    1. Azevedo CJ, Cen SY, Khadka S, Liu S, Kornak J, Shi Y, et al. . Thalamic atrophy in multiple sclerosis: a magnetic resonance imaging marker of neurodegeneration throughout disease. Ann Neurol. (2018) 83:223–34. 10.1002/ana.25150 - DOI - PMC - PubMed
    1. Radue E-W, Sprenger T, Gaetano L, Mueller-Lenke N, Cavalier S, Thangavelu K, et al. . Teriflunomide slows BVL in relapsing MS: a reanalysis of the TEMSO MRI data set using SIENA. Neurol Neuroimmunol Neuroinflamm. (2017) 4:e390. 10.1212/NXI.0000000000000390 - DOI - PMC - PubMed
    1. Pérez-Miralles FC, Sastre-Garriga J, Vidal-Jordana A, Río J, Auger C, Pareto D, et al. . Predictive value of early brain atrophy on response in patients treated with interferon β. Neurol Neuroimmunol Neuroinflamm. (2015) 2:e132. 10.1212/NXI.0000000000000132 - DOI - PMC - PubMed